HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MicroRNA-335-5p suppresses voltage-gated sodium channel expression and may be a target for seizure control.

Abstract
There remains an urgent need for new therapies for treatment-resistant epilepsy. Sodium channel blockers are effective for seizure control in common forms of epilepsy, but loss of sodium channel function underlies some genetic forms of epilepsy. Approaches that provide bidirectional control of sodium channel expression are needed. MicroRNAs (miRNA) are small noncoding RNAs which negatively regulate gene expression. Here we show that genome-wide miRNA screening of hippocampal tissue from a rat epilepsy model, mice treated with the antiseizure medicine cannabidiol, and plasma from patients with treatment-resistant epilepsy, converge on a single target-miR-335-5p. Pathway analysis on predicted and validated miR-335-5p targets identified multiple voltage-gated sodium channels (VGSCs). Intracerebroventricular injection of antisense oligonucleotides against miR-335-5p resulted in upregulation of Scn1a, Scn2a, and Scn3a in the mouse brain and an increased action potential rising phase and greater excitability of hippocampal pyramidal neurons in brain slice recordings, consistent with VGSCs as functional targets of miR-335-5p. Blocking miR-335-5p also increased voltage-gated sodium currents and SCN1A, SCN2A, and SCN3A expression in human induced pluripotent stem cell-derived neurons. Inhibition of miR-335-5p increased susceptibility to tonic-clonic seizures in the pentylenetetrazol seizure model, whereas adeno-associated virus 9-mediated overexpression of miR-335-5p reduced seizure severity and improved survival. These studies suggest modulation of miR-335-5p may be a means to regulate VGSCs and affect neuronal excitability and seizures. Changes to miR-335-5p may reflect compensatory mechanisms to control excitability and could provide biomarker or therapeutic strategies for different types of treatment-resistant epilepsy.
AuthorsMona Heiland, Niamh M C Connolly, Omar Mamad, Ngoc T Nguyen, Jaideep C Kesavan, Elena Langa, Kevin Fanning, Albert Sanfeliu, Yan Yan, Junyi Su, Morten T Venø, Lara S Costard, Valentin Neubert, Tobias Engel, Thomas D M Hill, Thomas M Freiman, Arun Mahesh, Vijay K Tiwari, Felix Rosenow, Sebastian Bauer, Jørgen Kjems, Gareth Morris, David C Henshall
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 120 Issue 30 Pg. e2216658120 (07 25 2023) ISSN: 1091-6490 [Electronic] United States
PMID37463203 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • MicroRNAs
  • Voltage-Gated Sodium Channels
  • MIRN335 microRNA, human
  • Scn1a protein, mouse
  • NAV1.1 Voltage-Gated Sodium Channel
  • Mirn335 microRNA, mouse
  • Scn3a protein, rat
  • NAV1.3 Voltage-Gated Sodium Channel
Topics
  • Humans
  • Mice
  • Rats
  • Animals
  • Induced Pluripotent Stem Cells (metabolism)
  • Seizures (chemically induced, genetics, metabolism)
  • Epilepsy
  • MicroRNAs (genetics, metabolism)
  • Voltage-Gated Sodium Channels (genetics)
  • NAV1.1 Voltage-Gated Sodium Channel (genetics, metabolism)
  • NAV1.3 Voltage-Gated Sodium Channel (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: